Cheminformatic Tools and Databases for Pharmacology

session 17346 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
ASCIMINIB

ASCIMINIB


ATC L01EA06

ANTINEOPLASTIC
ABL1 KINASE INHIBITOR
TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML)
INHIBITS THE ABL1 KINASE ACTIVITY OF THE BCR-ABL1 FUSION PROTEIN

ORAL

Cmax 12.5 MICROMOLAR

Tmax 2.5 HOUR

VD 151 LITER

PPB 97 PERCENT

Cl 4.1 LITER / HOUR

HT 9 HOUR

ABL1 KINASE

PDB 5MO4 (ABL1 KINASE (T334I_D382N) IN COMPLEX WITH ASCIMINIB AND NILOTINIB)

LIGAND CODE = AY7 (link to the list of PDB complexes)

Download experimental 3D coordinates of AY7 with added hydrogens

Tyrosine-protein kinase ABL1 UNIPROT P00519

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |